Analysis of etiological factors for emergence of endometrial hyperplasia in perimenopause
- risk factors,
- endometrial hyperplasia
How to Cite
Copyright (c) 2019 Aneta Sima, Anita Arsovska, Slagjana Simeonova, Krstevska, Ana Daneva Markova, Drage Dabeski
This work is licensed under a Creative Commons Attribution 4.0 International License.
The aim of this study was to evaluate the possible reasons for the emergence of endometrial hyperplasia in perimenopause. Material and methods: A total of 71 patients with irregular bleeding were analyzed, at the age of 40-50 years, who should have undergone diagnostic curettage. Depending on the histopathological findings, we divided them into 2 groups: group 1-findings for endometrial hyperplasia, group 2 - atrophic or endometrium with deficient secretory changes. Body mass index (BMI) was determined (obesity defined with BMI >30 kg/m2); we measured blood pressure (cut-off value was 135/90 mmHg), waist circumference (cut-off value was 88 cm) as well as data of anamnesis (age, physical activity, type of diet, smoking cigarettes). All these data were analyzed as etiological factors in the emergence of endometrial hyperplasia.Results: The mean age of patients was 47 years, and the results obtained were very similar in both examined groups. BMI and waist circumference were increased, more than 60% of patients had hypertension, but not all had a statistical significance. Most of them were with completed secondary education, and city living statistically significantly increases the risk of endometrial hyperplasia (p <0.05). As for the lifestyle (physical activity, caloric diet, smoking), the results have shown that a small number of patients are active, almost half of them consume caloric food and smoke, but without a statistical significance.Conclusion: Increased body weight and elevated blood pressure have a major impact on the onset and progression of pathological changes in the endometrium. As clinicians, we should always think of hyperplasia in obesity and patients with hypertension who are irregularly bleeding. At the same time, we should educate them to change the lifestyle in order to prevent gynecological and internistic morbidity.
- Zacur HA, Giuntoli RL, Jurema M. Endometrial Hyperplasia. UpToDate Online. Retrieved 2007; 5-26.
- Getpook C, Wattanakumtornkul S. Endometrial thickness screening in premenopausal women with abnormal uterine bleeding. J Obstet Gynaecol Res 2006;32:588-592.
- Emons G, Beckmann MW, Schmidt D, Mallmann P. Uterus commission of the Gynecological Oncology Working Group (AGO). New WHO Classification of Endometrial Hyperplasias. Geburtshilfe Frauenheilkd 2015; 75 (2):135-136.
- Ricci E, Moroni S, Parazzini F, Surace M, Benzi G, et al. Risk factors for endometrial hyperplasia: results from a case-control study. Int J Gynecol Cancer 2002;12: 257-260.
- Ozdemir S, Celik C, Gezginí§ K, KireÅŸi D, Esen H. Evaluation of endometrial thickness with transvaginal ultrasonography and histopathology in premenopausal women with abnormal vaginal bleeding. Arch Gynecol Obstet 2010; 282:395-399.
- Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, et al. Management of endometrial precancers. Obstet Gynecol 2012; 120 (5):1160-1175.
- World Health Organization Western Pacific Region. The Asia-Pacific perspective: redefining obesity and its treatment. Geneva: 2000.
- Thurston RC, Sowers MR, Sutton-Tyrrell K, Everson-Rose SA, Lewis TT, Edmundowicz D, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008;15:429-434.
- Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978; 89:157-161.
- Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016. JAMA 2018; 319(16) : 1723–1725.
- U.S. Preventive Services Task Force. Screening for obesity in children and adolescents: Recommendation statement. Am Fam Physician 2011; 83(6):739-740.
- Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension. An age-old debate. Hypertension 2008;51:952-959
- Gierach GL, Johnson BD, BaireyMerz CN, Kelsey SF, Bittner V, Olson MB, et al. Hypertension, menopause and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006;47:50S-58S.
- Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study. Eur Heart J 2007;28:2937-2943.
- Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension 2005;46:249-254.
- Maas AHEM, Franke HR. Women's health in menopause with a focus on hypertension. Netherlands Heart Journal 2009;17(2):68-72.
- Carr MC. The emerge of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411.
- Wise, Michelle R. et al. Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review. American Journal of Obstetrics & Gynecology 2016; 214(6): 689.e1 - 689.e17
- Paley CA, Johnson MI. Abdominal obesity and metabolic syndrome: exercise as medicine? BMC Sports Sci Med Rehabil. 2018;10:7.